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Validity is not an inherent property of a measurement scale and so evidence for validity
relating to its use for particular purposes, with defined populations and in specified
contexts must be accumulated. We have published the development of a web-based,
generic health-related quality of life instrument (VetMetricaTM) to measure the affective
impact of chronic disease in cats and provided evidence for its validity in a mixed
population of cats, some of which, according to veterinary judgement, were healthy
and others of which were suffering from chronic conditions likely to affect their quality
of life, often with multiple co-morbidities present. The first aim of the current study was
to demonstrate the construct validity of the VetMetricaTM generic instrument when used
with cats suffering from osteoarthritis, by testing the hypothesis that the health-related
quality of life profile of cats with different severities of osteoarthritis would differ and by
demonstrating convergent validity between the health-related quality of life profile scores
and independently quantified vet-assessed pain and quality of life impact scores. The
latter involved simple correlation analysis and investigation of the relationship between
health-related quality of life domain scores and vet-assessed scores, when adjusted
for other potential explanatory variables including number of comorbidities and age.
Responsiveness—the ability to detect clinically relevant change—is an essential quality
for an evaluative instrument and it also provides evidence for “longitudinal validity”.
Therefore, a second aim of this study was to demonstrate that changes in health-related
quality of life domain scores concurred with the clinician’s impression of change over
time in the health status of cats with osteoarthritis, thus providing evidence for the
instrument’s responsiveness. Previously, we have reported disagreement between owner
and vet impression as to health status in cats in general, but not in relation to any
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specific disease. Accordingly, the third study aim was to investigate the extent of
agreement or disagreement between owner impression of the impact of osteoarthritis
on their cats’ quality of life and vet impression of such impact. Fifty one percentage
of cat owners believed their cats to be perfectly healthy despite a clinician diagnosis
of osteoarthritis
Keywords: health–related quality of life, construct validity, responsiveness, osteoarthritis, owner opinion, known
groups, convergent validity, co-morbidities
INTRODUCTION
Osteoarthritis (OA) is a common painful chronic disease in
cats with a greater prevalence than was previously recognised
(1). Its effective management is underpinned by the ability to
measure pain reliably, and thus suitable measures of clinical
impact are required. Such instruments should monitor pain
effectively in an individual, enabling the selection of treatment
with known efficacy. Several owner-report clinical metrology
instruments have been developed (2, 3), which measure the
functional limitations caused by OA, whilst there has also been
interest in developing activity monitors for cats (4). However,
the contemporary approach to pain measurement focuses on its
affective dimension, which describes pain’s unpleasantness i.e.,
the unpleasant feelings that are experienced which cause the
suffering associated with pain (5). It has been suggested that a
more comprehensive understanding of the affective component
may be of fundamental importance to the development of
treatments for chronic and neuropathic pain (5). Given that
chronic pain in people interacts in a complex way with a person’s
emotional (social and psychological) and physical well-being,
many human chronic pain instruments primarily measure the
impact of the pain on quality of life (QOL) (6–8). Similarly, for
veterinary orthopaedic studies, guidelines have been published
that recognise the important contribution of the latter, given
the recommendation that at least one owner-reported QOL
instrument should be included, alongside at least one validated
functional outcome (such as activity monitors and clinical
metrology instruments) (9).
Quality of life is, like pain, a multi-dimensional construct
that is subjectively experienced. We have previously defined
animal QOL as an individual’s evaluation of its circumstances,
which results in or includes an affective state (10) and health-
related quality of life (HRQL) as the subjective evaluation
of circumstances that include altered health state and related
interventions (11). Instruments designed to measure HRQL can
be disease-specific, designed for particular conditions and their
treatment, or they can be generic, designed for use in a variety
of contexts in which health is good or is poor for a variety
of reasons, see (12) for a comprehensive list. Such instruments
either generate a single index score, which indicates that a patient
is better or worse (12, 13) or a profile of scores which offers more
information and may be more sensitive to group differences and
to changes in health status over time (12, 14).
Previously, we have published the development, initial
validation and reliability of a web-based, generic HRQL
instrument (VetMetricaTM) to measure the affective impact
of chronic disease in cats (15). This structured questionnaire
instrument is presented in an online survey format and takes the
owner, on average, 5min to complete. It contains 20 behaviour-
based items to which the cat owner responds using a 7-point
Likert scale (0 = could not be less to 6 = could not be more),
enabling a profile of scores in 3 HRQL domains of Vitality,
Comfort and Emotional wellbeing (EWB) to be generated.
Subsequently, we have modified the scoring in three ways to
improve interpretability: by normalising the scores to be centred
at the healthy population average, by determining a score cut-off
point that allows the user to classify a cat as sick or healthy, and
by calculating the Minimal Important Difference (MID) in the
normalised score to define a clinically significant improvement
in each domain (16).
Validity is the most important property of a measurement
instrument. It provides evidence that the instrument is able
to measure the construct that it was intended to measure.
Instrument developers should seek evidence for validity of three
principal kinds: content, criterion and construct validity (17, 18).
Criterion validity is demonstrated by the agreement of a new
instrument with some existing “gold standard”, but a suitable
gold standard does not always exist as was the case here. In our
earlier study (15) we reported evidence for the content validity
of the VetMetricaTM instrument which was determined using
content validity indices for relevance (CVIR) and clarity (I-CVIC)
of each item, and some initial evidence for the instrument’s
construct validity by testing the instrument using a cohort of
healthy cats and cats whose medical condition was deemed by
the attending clinician to affect their QOL. Construct validation
in that study (15) used factor analysis (FA) and hypothesis testing
using “known groups” (17, 19, 20) (the hypotheses being that the
HRQL profile of scores would differ between healthy cats and sick
cats, and that the HRQL profile would be worse for cats with
poorer health status defined by the number of co-morbidities
present in individuals). In addition to such FA and “known
groups” approaches to construct validation, developers can also
seek evidence for convergent validity, a subtype of construct
validity, where two measures that theoretically should be related
to each other are shown to be so related (21).
Validity is the most important quality of any measurement
instrument, and a body of evidence for validity must be
accumulated in relation to its use for particular purposes,
with defined populations and in specified contexts (22). Some
evidence for the validity of the VetMetricaTM instrument has
already been provided for the measurement of HRQL in a
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mixed population of cats, some of which, according to veterinary
judgement, were healthy and others of which were suffering from
chronic conditions likely to affect their QOL, often with multiple
co-morbidities present. Generic instruments have been shown to
perform satisfactorily for specific disease states in people, such as
Crohn’s Disease (23), OA (24), cardiac disease (25) and asthma
(26), and generic instruments to measure QOL in animals should
be able to be used in a similar way, with appropriate validation.
Consequently, the first objective of the current study was
to seek evidence for the construct validity of the VetMetricaTM
generic instrument when used with cats suffering from OA,
by testing the hypothesis that the HRQL profile of cats with
different severities of OA would differ and by demonstrating
convergent validity between the HRQL profile scores and
independently quantified vet-assessed pain and QOL impact
scores. Convergent validity was demonstrated both by simple
correlation analysis and by investigating the relationship between
HRQL domain scores and vet-assessed scores, when adjusted
for other potential explanatory variables including number of
comorbidities and age.
Whilst the most important property of a scientifically robust
health measurement instrument is validity, responsiveness—
the ability to detect clinically relevant change—is an essential
practical quality for an evaluative instrument and has been
suggested to also provide evidence for “longitudinal validity”
(27). Therefore, a second objective of this study was to
demonstrate that changes in HRQL domain scores concurred
with the clinician’s impression of change over time in the
health status of cats with OA, thus providing evidence for the
instrument’s responsiveness.
Previously, we have reported disagreement between owner
and vet impression as to health status in dogs (28) and cats
in general (15), but not in relation to any specific disease. In
the latter publication the results of two independent field tests
showed that 29 and 26% of owners of cats, deemed to be
unhealthy following clinical assessment, believed their cats to
be in perfect health. Accordingly, the third study objective was
to investigate the extent of agreement or disagreement between
owner impression of the impact of OA on their cats’ QOL and vet
impression of such impact.
METHODS
Data Collection for Objectives 1, 2, and 3
The University of Glasgow School of Veterinary Medicine Ethics
andWelfare Committee approved the work andwritten informed
consent was obtained from the owners for the participation of
their animals in these studies.
Data were collected from owners of 56 cats with a diagnosis
of OA attending first opinion practises, feline specialist practises,
and the University of Glasgow Small Animal Hospital (UGSAH)
for previously conducted field studies relating to the feline
VetMetricaTM HRQL instrument (15). Additionally, data were
collected from 84 cats diagnosed with OA attending the Royal
Canin Healthy Ageing Clinic, University of Liverpool and
participating in the Cat Prospective Ageing and Welfare Study
(CatPAWS). The latter is a longitudinal cohort study, established
in 2016, to monitor pet cats during the ageing process. Cats
are enrolled from the ages of 7–10 years and then followed
prospectively by health evaluations on a biannual basis. Data are
collected on physical, biochemical and clinical parameters, as well
as QOL. All 140 owners completed at least one VetMetricaTM
HRQL assessment online. In addition to the 20 questions
comprising the VetMetricaTM instrument, owners were asked
the following questions, personalised to their cat, in order to
ascertain the owners’ impression of their cat’s QOL:
1. How would you rate (your cat’s) quality of life?—very
poor/poor/good/very good.
2. Is (your cat) currently in perfect health?—Yes/No.
3. If not, how much do you think (your cat’s) health status is
affecting the quality of life?—not at all/a little/somewhat/a lot.
These questions were independent of the 20 items comprising the
HRQL assessment.
Concurrently, the attending vet was asked to complete
a veterinary assessment comprising a list of common feline
diseases, from which they recorded the presence and severity
(mild/moderate/severe/end stage) for each cat. A freeform box
allowed them to add a disease not specified in the list. They were
also asked to complete the following questions:
1. On a scale of 0–10 with 0 being no impact and 10 being the
most impact, please assess how much the cat’s health status is
reducing its quality of life (QoL):
No impact 0 1 2 3 4 5 6 7 8 9 10 Impact could not be greater.
2. On a scale of 0 to 10 with 0 being no pain and 10 being the
pain could not be worse, please indicate what amount of pain
you feel the cat is suffering?
No pain 0 1 2 3 4 5 6 7 8 9 10 Pain could not be worse.
3. How has the cat’s general health status changed since the
previous consultation?
Much worse/worse/unchanged/better/much better.
All data are available in the Supplementary Material.
Objective 1–Construct Validity
Evidence for construct validity was sought using “known groups”
and convergent validity approaches.
Statistical Analysis
The first owner and vet assessment pair were used for the
statistical analysis. Data were analysed using Minitab R© 19
Statistical Software (2010) (www.minitab.com) and with an
open-source statistical software environment (R, version 4.0.2, R
Foundation for Statistical Computing, Vienna, Austria).
The level of statistical significance was set at 5% (p < 0.05) for
all analyses.
Known Groups Validity
Aone-wayANOVAwas used to determine whether the difference
between known groups (mild OA and moderate/severe OA) was
statistically significant. Our prior hypothesis was that HRQL
domain scores would vary between groups such that those for
cats with mild OA would be greater than those for cats with
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moderate/severe OA HRQL scores, since higher scores represent
better HRQL.
Convergent Validity
A Pearson correlation coefficient was used to determine the
correlation (and convergent validity) of the 3 HRQL domain
scores (Vitality, Comfort and EWB) and the vet-assessed QOL
impact and pain scores. Further, linear models were fitted to
explore the effects of age and other co-morbidities on the
relationship between the vet-assessed QOL impact and pain
scores, and the HRQL domain scores. In each case, the response
was the vet-assessed score (QOL impact or pain), and the
explanatory variables were the HRQL domain scores, age and
number of co-morbidities. Non-significant explanatory variables
(p > 0.05) were removed and the final model was reported.
Objective 2: Responsiveness
Statistical Analysis
Using the 140-cat data set for Objective 1 where the owner had
completed multiple assessments and where an available paired
veterinary assessment was completed within ≤14 days of each
owner assessment, change in HRQL scores was calculated as
the difference between two consecutive observations. To assess
whether the change in HRQL score reflected the direction of
change in vet-assessed pain and QOL impact, individual t-tests
were carried out for each HRQL domain within each direction of
change (decrease, no change and increase) for vet-assessed pain
and QOL impact scores. In the case of a decrease in the vet-
assessed scores, a one-sided t-test was used with the hypothesis
that there would be a positive change in HRQL domain score.
Similarly, a one-sided t-test was used in the case of an increase in
the vet-assessed scores with the hypothesis that there would be a
negative change in HRQL domain score. Finally, a two-sided t-
test was used in the case of no-change in the vet-assessed scores.
In each case the significance level was set at 5%, with a p < 0.05
indicating a significant relationship. For one-sided analyses, the
confidence intervals may be unbounded, and the results in this
case are presented as either >limit or <limit.
Objective 3–Agreement Between
Veterinarian and Owner Global
Assessments of QOL
Boxplots were constructed to examine the relationship between
the veterinarian’s assessment of impact on QOL and the owner’s
impression of their cat’s QOL, and between the veterinarian’s
assessment of impact on QOL and the owner’s impression of how
much their cat’s health status was impacting its QOL. Pairwise
comparisons between groups were assessed using two sample
t-tests (1 and 2 -sided) and 95% confidence intervals.
RESULTS
Objective 1
Owners of 140 cats, median age 10 years (range, 2–20 years;
Figure 1) completed a first assessment; 80 were female, 60 were
male and most were neutered, with various breeds represented
(Table 1).
Known Groups Validity
There were only nine occasions when cats were considered to
have severe OA so these were included with the moderately
affected cats to form a moderate/severe group. Figure 2 is an
interval plot of the mean and confidence intervals for HRQL
scores in Vitality, Comfort and EWB for 140 cats with mild
or with moderate/severe OA as determined by an attending
veterinarian. All the mean scores were <50.0, representing the
healthy population average, whilst all mean scores were <44.8
above which 70% of healthy cats will score (14). For all three
domains, the mean HRQL domain score was less for cats in
the moderate-severe OA group compared with the mild OA
group (Table 2; p < 0.001 for all), providing evidence for
construct validity.
Convergent Validity
Seventeen veterinarians did not complete QOL impact and pain
scores. Consequently this analysis was conducted on results from
123 cats. There were weak negative associations (29) between
both the veterinary pain and QOL score and all three HRQL
domains (Table 3; p< 0.001 for all). These statistically significant
negative correlations indicated that as vet-assessed pain and QOL
impact scores increased, the HRQL domain scores decreased,
providing additional evidence for construct validity (Table 3).
Effects of Age and Other Co-morbidities on the
Relationship Between the Vet-Assessed QOL Impact
and Pain Scores and the HRQL Domain Scores
Apart from 11 cats that had OA with no co-morbidities (CM)
reported, the remainder of the cats suffered from a variety of co-
morbidities (median 2, range 0–7), the most commonly reported
being dental disease, chronic kidney disease and other chronic
medical conditions, which the veterinarians were not asked to
specify. For the purpose of the analysis the comorbidity score was
categorised as either≤3 and >3 comorbidities.
A separate regression model for vet-assessed QOL impact and
pain scores with each HRQL domain score, age and number
of comorbidities was first fitted, and then variable selection
(removal of all explanatory variables which were not statistically
significant) carried out. For vet-assessed QOL impact, the
categorised number of co-morbidities and each HRQL domain
score were found to be statistically significant (Table 4). The
mean vet-assessed QOL impact score was higher where there
were more than three co-morbidities, and as each HRQL score
increased, the QOL impact score decreased. Overall, between
10 and 14% of the variation in QOL impact was explained.
For vet-assessed pain scores, age was statistically significant, as
was the categorised number of co-morbidities. As the HRQL
domain score increased when accounting for age, the pain score
decreased, as age increased so did the pain score, and pain
scores were on average higher in the >3 co-morbidities category.
Overall, between 17 and 20% of the variation in pain score was
explained by age, co-morbidities and the HRQL domain score.
These regression analyses reveal anticipated relationships
between HRQL domain scores and vet-assessed QOL impact and
pain, after accounting for age and number of co-morbidities,
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FIGURE 1 | Age distribution of 140 cat subjects with osteoarthritis.
TABLE 1 | Distribution of breeds for study cats (N = 140).
Breed Number of cats
Domestic Short Hair 100
Domestic Medium Hair 3
Domestic Long Hair 10
Siamese 10
Burmese 2
British Short Hair 5
Bengal, Ragdoll, Persian Long Hair, Persian,
Oriental Short Hair, Ocicat, Maine Coon,
European Short Hair, Egyptian Mau, Balinese
One of each breed
which provides further evidence of convergent validity and so for
the construct validity of the instrument.
Objective 2
In seven cats date-matched observations were not available: for
the remaining 133 cats there were 267 matched (owner and vet)
observations. There were a total of 134 change measurements
(from 74 cats) where two consecutive matched observations met
the 14-day interval criterion. Thirty-seven of these cats had one
change measurement, 21 had two, nine had three and seven had
four. The average time between vet visits for cats with more than
one change measurement was 176 days.
The results for the change in HRQL domain scores for each
type of change in vet-assessed pain and QOL impact are shown
in Figure 3; Table 5. For vet-assessed pain score, there were
no significant changes in any HRQL domains in cats where
no change in pain score was reported on the vet assessment.
However, in cats where pain score increased, HRQL domain
scores decreased for Comfort (p = 0.015) and EWB (p = 0.022)
but not Vitality (p = 0.194), whereas, in cats where pain score
decreased, HRQL scores for Vitality (p = 0.009) and EWB
increased (p = 0.004), but there was no change in Comfort score
(p = 0.145). For the vet-assessed QOL impact score, there also
were no significant changes in any HRQL domains in cats where
no change in veterinary score was reported. Further, in cats whose
vet assessment QOL impact score increased, domain scores for
Comfort (p = 0.011) and EWB (p = 0.016), but not vitality
(p = 0.736), decreased; conversely, for cats whose vet-assessed
QOL impact score decreased, domain scores for Vitality (p =
0.018) and EWB (p = 0.004) increased but the domain score for
comfort did not (p= 0.137).
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FIGURE 2 | Interval plot of the mean and confidence intervals for health-related quality of life (HRQL) scores in Vitality, Comfort and Emotional Wellbeing (EWB)
domains for 140 cats with mild (n = 88) or moderate/severe (n = 52) osteoarthritis. The dotted line indicates the score (50) which represents the healthy population
average while the broken line represents the threshold score (44.8) above which 70% of healthy cats lie.
Objective 3
Seventy-one of 140 cat owners believed their cat to be in perfect
health despite a veterinary diagnosis of OA. Accordingly, analysis
was restricted to the 69 remaining cats, except for five whose
veterinarians had not recorded QOL impact or pain scores. There
was only one cat where the owner classified its QOL as very poor
so, for subsequent analysis, the very poor and poor categories
were combined. Figure 4; Table 6 show the agreement between
the vet-assessed QOL impact score and the owner’s impression of
their cat’s QOL. Although the number of cats in the poor/very
poor category was small (4), there was a general trend with
declining vet-assessed QOL impact scores as the owners’ QOL
impressions changed from poor through to very good. The vet-
assessed QOL impact score categorised by the owner’s impression
of QOL impact indicated that, as the owners’ impression changed
from not at all to a lot, the vet QOL impact score followed
this trend (Figure 5; Table 6). There were statistically significant
differences between the mean vet assessed QOL impact scores for
the two end categories for owner QOL status (very good and very
poor/poor) and QOL impact (not at all and a lot) (Table 6).
DISCUSSION
The aim of Objective 1 was to seek evidence for the construct
validity of the VetMetricaTM instrument for use with cats
suffering from OA, by testing the hypothesis that the HRQL
profile of cats with different severities of OA would differ.
The small group of severely affected cats restricted this to a
comparison of just two groups (mild and moderate/severe) The
results demonstrated that all mean HRQL domain scores for
both groups fell below those of the average healthy cat (16) and
there was a trend across all three domains for HRQL scores to
decrease as the severity of disease increased. The difference in
scores was highly significant (p = <0.001) in all three HRQL
domains, supporting our hypothesis.
The sensitivity of the tool to disease severity represents a
significant advantage over existing tools, namely the Feline
Musculoskeletal Pain Index (FMPI), a disease specific clinical
metrology instrument (2), and the Montreal Instrument for Cat
Arthritis Testing, for use by Veterinarians (MI-CAT[V]) (3), both
of which have been shown to distinguish only between normal
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TABLE 2 | Descriptive statistics for three HRQL domains, vitality, comfort and emotional wellbeing (EWB) for mild (n = 88) and moderate/severe (n = 52) groups of cats
affected by OA.
Domain Severity Mean SD Minimum Q1 Median Q3 Maximum
Vitality Mild 43.57 11.60 11.47 37.92 44.16 52.15 63.99
Moderate/severe 34.21 12.11 0.05 28.24 34.42 43.56 56.07
Comfort Mild 42.45 10.25 22.02 34.74 40.15 51.40 59.55
Moderate/severe 32.91 8.09 15.71 27.53 31.47 37.00 59.55
EWB Mild 44.09 13.34 8.26 34.59 47.34 55.02 58.84
Moderate/severe 34.41 14.67 0.00 28.67 36.32 45.97 58.84
TABLE 3 | Pearson correlation coefficients and respective P values for the
reported comparisons between Vitality, Comfort and Emotional Wellbeing (EWB),
and the vet-assessed pain and QOL impact scores.
Vet QOL impact score Vet pain score
Vitality −0.35 (p = <0.001) −0.35 (p = <0.001)
Comfort −0.33(p = <0.001)) −0.39 (p = <0.001)
EWB −0.22 (p = 0.017) −0.26 (p = 0.004)
cats and cats with OA. However, this is perhaps not surprising
since both of these instruments rely on the detection of functional
limitations with no regard to the emotional impact of the OA
pain experience which has been described previously (30), and
which causes changes in a variety of behaviours including social
interaction, vocalisation and playing and hunting. In contrast,
the VetMetricaTM HRQL tools are holistic measures which have
a focus on the emotional as well as the physical impact of
disease (12, 15) which appears to result in better discrimination
of disease severity.
Furthermore, the demonstration of convergent validity
between HRQL domain scores and the independently quantified
vet-assessed pain and QOL impact scores supports the construct
validity of the generic HRQL scale in cats with OA. An
initial simple approach using Pearson correlation coefficients
was adopted and the negative correlations for both vet-assessed
scores and all HRQL domain scores demonstrated that as vet-
assessed pain and QOL impact scores increased, HRQL domain
scores decreased, providing evidence for convergent validity.
All coefficients were statistically significant, but were within the
range 0.20–0.39 which suggests a weak relationship between these
variables (29). However, confounding factors may be that most of
the cats were aged 7 years and older (Figure 1) and all but 11 had
co-morbidities. Accordingly, it was decided to further investigate
the relationship between vet-assessed pain and QOL impact
scores and HRQL domain scores by jointly modelling the effects
of age and co-morbidities to take account of these confounding
factors. The regression modelling showed that for vet-assessed
pain, the model was improved by including age and the number
of co-morbidities. This was not unexpected since older cats are
likely to be in greater pain because of the higher incidence of co-
morbid conditions, many of which are likely to cause pain (15).
In contrast, for vet-assessed QOL impact, the relationship with
the HRQL domains was improved by including the number of
co-morbidities, but not age. This concurs with previous findings
which have shown that as co-morbidities increase in cats, HRQL
scores decrease indicating a poorer quality of life (15). However, it
is the case that all the models explained only a small percentage of
the variation in the vet-assessed scores suggesting there are other
factors which veterinarians use in their subjective judgements
that are not part of the owner assessments. A variety of factors can
affect the subjective assessment of pain by veterinarians including
their age, sex and year of graduation (31–34) and these may have
influenced the vet-assessed pain scores. The assessment of pain
is fundamental to effective pain management so veterinarians are
very conversant with pain assessment, but less so when it comes
to assessment of QOL. Indeed, it could be argued that because
veterinarians are not familiar with the day-to-day behaviour of
their patients in the home environment they are disadvantaged
when asked to assess the impact of disease on QOL. This may
be an explanation for the fact that <15% of the variation in vet-
assessed QOL impact scores was accounted for in the model.
Nevertheless, the results support the convergent validity of the
instrument, going beyond the basic correlation analysis to take
account of other relevant factors (age and co-morbidities) and
show that the HRQL domain scores are related to the vet-assessed
scores as would be predicted.
Responsiveness is recognised to be an essential quality in any
evaluative HRQL instrument but there are different views on
how it should be defined and assessed (27). Broadly speaking,
responsiveness has been defined as the ability to detect general
change (35), which is expressed as a statistically significant
change after treatment; as the ability to detect clinically important
change (36), which requires a subjective judgement by a
patient/carer/clinician as to what constitutes importance; and as
the ability to detect true change in the construct (37), which was
the definition adopted in this study. Linked to these definitions
are a number ofmethods by which responsiveness can be assessed
and the method chosen for this study was to demonstrate that
the VetMetricaTM feline instrument could discriminate between
those cats whose health status had improved, deteriorated or
remained unchanged according to the veterinarian, using t-tests.
Because in some cases more than one observation per
cat was used, it could be argued that the independence
assumption required for the t-tests was not satisfied. However,
the average time between observations in those cats with multiple
observations was around 6 months and on that basis the
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TABLE 4 | Results from regression model fitted with vet-assessed QOL impact and pain scores, and HRQL domains Vitality, Comfort and Emotional wellbeing (EWB),
taking into account age (in years) and the number of co-morbidities (CM) present.
Response Vitality (p-value) Comfort (p-value) EWB (p-value)
Vet pain score Vitality: −0.039 (0.017) Comfort: −0.059 (0.003) EWB: −0.028 (0.04)
Age: 0.123 (0.03) Age: 0.102 (0.07) Age: 0.135 (0.017)
CM: 0.899 (0.06) CM: 0.936 (0.045) CM: 1.145 (0.015)
Vet QOL impact score Vitality: −0.054 (0.003) Comfort: −0.062 (0.005) EWB: −0.031 (0.048)
CM: 1.23 (0.023) CM: 1.34 (0.011) CM: 1.652 (0.002)
FIGURE 3 | Boxplots of change in the three health related quality of life (HRQL) domain scores according to change in 134 vet-assessed quality of life (QOL) impact
and pain scores from 74 cats.
TABLE 5 | Changes in health-related quality of life domain scores, Vitality, Comfort and Emotional Wellbeing (EWB) with respect to change in vet-assessed pain score
(VAP) and vet-assessed QOL impact score (VQOLI).
HRQL Score Decrease in VAP No Change in VAP Increase in VAP
p Mean (95% CI) p Mean (95% CI) p Mean (95% CI)
Vitality 0.009 6.35 (>2.15) 0.891 0.10 (−1.33, 1.53) 0.194 −1.64 (<1.55)
Comfort 0.145 1.68 (>-0.99) 0.379 −0.65 (−2.12, 0.81) 0.015 −4.43 (<-1.14)
EWB 0.004 9.90 (>4.23) 0.597 −0.55 (−2.63, 1.52) 0.022 −3.88 (<-0.75)
HRQL Score Decrease in VQOLI No Change in VQOLI Increase in VQOLI
p Mean (95% CI) p Mean (95% CI) p Mean (95% CI)
Vitality 0.018 5.35 (>1.27) 0.317 −0.80 (−2.39, 0.78) 0.736 0.89 (<3.24)
Comfort 0.137 1.78 (>-0.95) 0.471 −0.58 (−2.19, 1.02) 0.011 −3.37 (<-0.99)
EWB 0.004 9.96 (>4.23) 0.891 −0.14 (−2.12, 1.85) 0.016 −3.76 (<-0.92)
Values represent mean (and 95% confidence intervals) change in HRQL domain score, along with the associated P values.
Frontiers in Veterinary Science | www.frontiersin.org 8 September 2021 | Volume 8 | Article 733812
Scott et al. HRQL in Cats With Osteoarthritis
FIGURE 4 | Boxplot of the vet-assessed quality of life (QOL) impact score (scale 0–10, where 0 is no impact and 10 is maximum possible impact) and the owner’s
impression of their cat’s QOL (poor/very poor; good; very good).
TABLE 6 | Comparison of quality of life (QOL) impact score in the vet assessment and owner impressions of their cat’s QoL.
Owner impression Vet assessment
Owner impression of QOL Number QOL impact scorea Difference between end categoriesb
Poor 4 7.88 +/– 1.50 4.43 (2.19, 6.68) P = 0.002
Good 41 3.66 +/– 2.33
Very good 19 3.32 +/– 2.54
Impact of disease on QOL
Not at all 9 2.22 +/- 2.22 3.44 (1.13, 5.76) P = 0.007
A little 35 3.43 +/- 2.38
Somewhat 14 4.77 +/- 2.96
A lot 16 5.67 +/- 1.86
aValues represent mean ± standard deviation for vet-assessed quality of life (QOL) impact score.
bValues represent mean (95% confidence interval) difference between vet-assessed QOL impact score for cats in end categories for owner impression of QOL (poor vs. very good) and
Impact of disease on QOL (Not at all vs. A lot), along with associated P value.
authors suggest that these could be considered independent.
Furthermore, the observations were divided between the three
different types of change in the vet-assessed pain andQOL impact
scores (decrease, no change and increase) meaning the number of
observations from the same cat in any sample was limited. Also in
each case, it was the change in both the HRQL domain scores and
the vet-assessed pain and QOL impact scores which were used,
resulting in any trend for a given cat (e.g., disease progression)
being removed, and similarly any effect of systematically higher
or lower scores in a given cat being accounted for.
When both vet-assessed pain and QOL scores decreased,
indicating an improvement in health status, all HRQL domains
showed a positive change which concurred with the assumption
that the cat’s health had improved. However only in Vitality
and EWB domains were the changes significant. These HRQL
domains tend to reflect the affective (emotional) component of
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FIGURE 5 | Vet-assessed quality of life (QOL) impact score (scale 0–10, where 0 is no impact and 10 is maximum possible impact) categorised by the owner’s
impression of QOL impact.
the pain/QOL experience, which may be most likely to change
in response to treatment, while the Comfort domain contains
items relating to the impairment in physical function caused by
OA. It is a limitation of this study that information regarding
treatment for their OA was not reported for all cats and many,
especially those with mild disease, are unlikely to have received
any therapeutic intervention. Similarly, when the vet-assessed
pain and QOL scores increased, indicating a deterioration in
health status, there was a decrease in HRQL domain scores, but
again only two domains, Comfort and EWB, reached statistical
significance while the Vitality domain did not. Previously we
have demonstrated more variation in the Vitality domain in
healthy cats than in Comfort and EWB domains (15) which may
have contributed to this finding. However, it is noteworthy that
although the complete sample size was moderate (134), only
20 and 27 cats, respectively, had decreased or increased vet-
assessed pain and QOL scores, with 87 cats recorded as having
not changed. Thus, the lack of significance in any domain scores
changes may be a consequence of small sample size.
Previously we have reported discordance between cat owners’
impression of health status and that of the veterinarian, by asking
the owners of cats with a veterinary diagnosis of illness, likely
to affect their QOL, if their pet was “in perfect health” and
in two separate field studies 29 and 26% of owners believed
their cats to be in perfect health (15). In the study reported
here 51% of owners of cats with a veterinary diagnosis of OA
believed their cats to be in perfect health which is considerably
higher. However, 63% of these cats were suffering from mild OA
according to their veterinarian, and owners may not recognise
the subtle signs of that degree of illness which may account for
the increase. These findings highlight the need for more owner
education in the field of OA recognition and management.
In this study we extended our previous more general approach
by seeking to determine if, when owners accepted that their
cats were not in perfect health, their impression of the QOL of
their cats with OA and associated co-morbidities concurred with
the veterinarian’s impression of QOL impact. There was little
difference in median QOL impact scores in owner reported QOL
between good and very good categories which may be due to
the difficulty experienced by owners when separating these. It is
notable that only four owners thought their cat had a poor/very
poor QOL which may be a consequence of social desirability
bias (38), when owners are reluctant to admit that their cats
have a less than optimum QOL because of the perceptions of
others. Similarly, there was little difference in the median QOL
impact scores between groups whose QOL was impacted a little
and somewhat according to the owners, suggesting difficulty
in distinguishing these groups. Also, a very small number of
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owners believed their cats to be at the ends of the scale; not
affected (n = 8) and affected a lot (n = 6). Notwithstanding
these observations, when the vet-assessed QOL impact scores
were compared for each of the owner reports for QOL and QOL
impact at the extremes of the scales there was a statistically
significant difference, validating each of these global assessments
and demonstrating concurrence between veterinarian and owner
impression of the impact of OA on HRQL.
The validity of any HRQL instrument must be supported by a
body of evidence which demonstrates that it is valid for particular
purposes, with defined populations and in specified contexts
(22) and the work reported in Objective 1 has—using known
groups and convergent validity approaches—provided evidence
for the construct validity of the feline VetMetricaTM generic
instrument for the measurement of HRQL of cats with OA–.
Furthermore, if responsiveness can be considered to provide
evidence of longitudinal validity (27) then the results of Objective
2 also add to the body of evidence supporting the instrument’s
validity for use with this new population.
The study has provided initial evidence for the responsiveness
of the instrument to clinical change in cats with OA,
an essential quality in an instrument designed for clinical
evaluation purposes. An important next step will be to facilitate
interpretation of score changes in a clinical or research context
by calculating a minimum important difference (MID) for cats
with OA. The MID has been defined as “the smallest difference in
score in the outcome of interest that informed patients or informed
proxies perceive as important, either beneficial or harmful, and
which would lead the patient or clinician to consider a change in
the management” (39). Previously we have reported MID values
for Vitality, Comfort and EWB domains in cats suffering from
a variety of chronic conditions (16), but the MID is not a fixed
property of the scale and will vary according to the population
and the context in which it is being used. A population of
cats with OA is likely to be less heterogeneous than that used
previously and so the MID values are likely to differ. Given the
number of clinical trials being conducted currently to develop
new therapeutic interventions for feline OA, the determination
of MID will assume increasing importance for the calculation of
sample size as this depends on the magnitude of the difference
investigators consider clinically important (40).
In conclusion, Objectives 1 and 2 have provided additional
evidence to support the validity of the feline VetMetricaTM
generic HRQL instrument and demonstrated its value as an
outcome measure in trials designed to demonstrate the efficacy
of therapeutic interventions for OA in the cat. Objective 3 has
shown that while a high proportion of owners of cats with OA
are reluctant to admit their cats are in ill health, those that do are
in agreement with their veterinarian’s impression of the impact
of the disease on their cats’ QOL.
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